These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33989083)

  • 41. Regulation of endothelial nitric oxide synthase in cardiac remodeling.
    Musicante M; Kim HH; Chen Y; Liao F; Bhattacharya SK; Lu L; Sun Y
    Int J Cardiol; 2022 Oct; 364():96-101. PubMed ID: 35654172
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pitavastatin, an HMG-CoA reductase inhibitor, exerts eNOS-independent protective actions against angiotensin II induced cardiovascular remodeling and renal insufficiency.
    Yagi S; Aihara K; Ikeda Y; Sumitomo Y; Yoshida S; Ise T; Iwase T; Ishikawa K; Azuma H; Akaike M; Matsumoto T
    Circ Res; 2008 Jan; 102(1):68-76. PubMed ID: 17967781
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ET-1 from endothelial cells is required for complete angiotensin II-induced cardiac fibrosis and hypertrophy.
    Adiarto S; Heiden S; Vignon-Zellweger N; Nakayama K; Yagi K; Yanagisawa M; Emoto N
    Life Sci; 2012 Oct; 91(13-14):651-7. PubMed ID: 22365964
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effects of clearance of superoxide anion by catechin on the expression of NO and eNOS and apoptosis in endothelial progenitor cells induced by angiotensin II].
    Wu LY; Dang XQ; He XJ; Yi ZW
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun; 11(6):476-80. PubMed ID: 19558814
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hydrogen peroxide differentially modulates cardiac myocyte nitric oxide synthesis.
    Sartoretto JL; Kalwa H; Pluth MD; Lippard SJ; Michel T
    Proc Natl Acad Sci U S A; 2011 Sep; 108(38):15792-7. PubMed ID: 21896719
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
    Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
    Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Angiotensin-(1-7) counteracts angiotensin II-induced dysfunction in cerebral endothelial cells via modulating Nox2/ROS and PI3K/NO pathways.
    Xiao X; Zhang C; Ma X; Miao H; Wang J; Liu L; Chen S; Zeng R; Chen Y; Bihl JC
    Exp Cell Res; 2015 Aug; 336(1):58-65. PubMed ID: 26101159
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cardiac angiotensin II type 2 receptor activates the kinin/NO system and inhibits fibrosis.
    Kurisu S; Ozono R; Oshima T; Kambe M; Ishida T; Sugino H; Matsuura H; Chayama K; Teranishi Y; Iba O; Amano K; Matsubara H
    Hypertension; 2003 Jan; 41(1):99-107. PubMed ID: 12511537
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lack of endothelial nitric oxide synthase promotes endothelin-induced hypertension: lessons from endothelin-1 transgenic/endothelial nitric oxide synthase knockout mice.
    Quaschning T; Voss F; Relle K; Kalk P; Vignon-Zellweger N; Pfab T; Bauer C; Theilig F; Bachmann S; Kraemer-Guth A; Wanner C; Theuring F; Galle J; Hocher B
    J Am Soc Nephrol; 2007 Mar; 18(3):730-40. PubMed ID: 17287431
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An oral formulation of angiotensin-(1-7) reverses corpus cavernosum damages induced by hypercholesterolemia.
    Fraga-Silva RA; Costa-Fraga FP; Savergnini SQ; De Sousa FB; Montecucco F; da Silva D; Sinisterra RD; Mach F; Stergiopulos N; da Silva RF; Santos RA
    J Sex Med; 2013 Oct; 10(10):2430-42. PubMed ID: 23890028
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Endothelial-derived extracellular vesicles from obese/hypertensive adults increase factors associated with hypertrophy and fibrosis in cardiomyocytes.
    Fandl HK; Garcia VP; Treuth JW; Brewster LM; Greiner JJ; Davy KP; Stauffer BL; Desouza CA
    Am J Physiol Heart Circ Physiol; 2023 May; 324(5):H675-H685. PubMed ID: 36930654
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endothelial Nitric Oxide Synthase-Derived Nitric Oxide Prevents Dihydrofolate Reductase Degradation via Promoting S-Nitrosylation.
    Cai Z; Lu Q; Ding Y; Wang Q; Xiao L; Song P; Zou MH
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2366-73. PubMed ID: 26381869
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Angiotensin-(1-7) reduces the perfusion pressure response to angiotensin II and methoxamine via an endothelial nitric oxide-mediated pathway in cirrhotic rat liver.
    Herath CB; Mak K; Burrell LM; Angus PW
    Am J Physiol Gastrointest Liver Physiol; 2013 Jan; 304(1):G99-108. PubMed ID: 23086915
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Knockdown of angiopoietin like-2 protects against angiotensin II-induced cerebral endothelial dysfunction in mice.
    Yu C; Luo X; Duquette N; Thorin-Trescases N; Thorin E
    Am J Physiol Heart Circ Physiol; 2015 Mar; 308(5):H386-97. PubMed ID: 25527773
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Depletion of ubiA prenyltransferase domain containing 1 expression promotes angiotensin II‑induced hypertrophic response in AC16 human myocardial cells via modulating the expression levels of coenzyme Q10 and endothelial nitric oxide synthase.
    Yan B; Sun Y; Wang J
    Mol Med Rep; 2017 Nov; 16(5):6910-6915. PubMed ID: 28901410
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endothelial nitric oxide synthase lies downstream from angiotensin II-induced angiogenesis in ischemic hindlimb.
    Tamarat R; Silvestre JS; Kubis N; Benessiano J; Duriez M; deGasparo M; Henrion D; Levy BI
    Hypertension; 2002 Mar; 39(3):830-5. PubMed ID: 11897773
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thalidomide ameliorates portal hypertension via nitric oxide synthase independent reduced systolic blood pressure.
    Theodorakis NG; Wang YN; Korshunov VA; Maluccio MA; Skill NJ
    World J Gastroenterol; 2015 Apr; 21(14):4126-35. PubMed ID: 25892862
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Guanylyl cyclase-A inhibits angiotensin II type 1A receptor-mediated cardiac remodeling, an endogenous protective mechanism in the heart.
    Li Y; Kishimoto I; Saito Y; Harada M; Kuwahara K; Izumi T; Takahashi N; Kawakami R; Tanimoto K; Nakagawa Y; Nakanishi M; Adachi Y; Garbers DL; Fukamizu A; Nakao K
    Circulation; 2002 Sep; 106(13):1722-8. PubMed ID: 12270869
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Disruption of Physiological Balance Between Nitric Oxide and Endothelium-Dependent Hyperpolarization Impairs Cardiovascular Homeostasis in Mice.
    Godo S; Sawada A; Saito H; Ikeda S; Enkhjargal B; Suzuki K; Tanaka S; Shimokawa H
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):97-107. PubMed ID: 26543099
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Generation of a conditional allele for the mouse endothelial nitric oxide synthase gene.
    Jiang R; Wang S; Takahashi K; Fujita H; Fruci CR; Breyer MD; Harris RC; Takahashi T
    Genesis; 2012 Sep; 50(9):685-92. PubMed ID: 22467476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.